Key stats
Fund info
Home page
Inception date
Nov 2, 2021
Structure
Irish ICAV
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
Carne Global Fund Managers (Ireland) Ltd.
ISIN
IE00BM8R0N95
FIGI
BBG01386ZGP9
Identifiers
ISIN IE00BM8R0N95
The Funds investment objective is to generate returns that closelyrncorrespond, before fees and expenses, generally to the price and yieldrnperformance of the Solactive Genomics v2 Index
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.61%
Health Technology95.41%
Health Services4.20%
Bonds, Cash & Other0.39%
Cash0.39%
Breakdown by region
North America85.11%
Europe10.18%
Asia4.72%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently asked questions
GNOM invests in stocks. The fund's major sectors are Health Technology, with 95.41% stocks, and Health Services, with 4.20% of the basket. The assets are mostly located in the North America region.
GNOM top holdings are Moderna, Inc. and Twist Bioscience Corp., occupying 9.41% and 8.00% of the portfolio correspondingly.
GNOM assets under management is 140.23 M USD. It's risen 101.91% over the last month.
GNOM fund flows account for 76.91 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, GNOM doesn't pay dividends to its holders.
GNOM shares are issued by Mirae Asset Global Investments Co., Ltd. under the brand Global X. The ETF was launched on Nov 2, 2021, and its management style is Passive.
GNOM expense ratio is 0.50% meaning you'd have to pay 0.50% of your investment to help manage the fund.
GNOM follows the Solactive Genomics v2 Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
GNOM invests in stocks.
GNOM price has risen by 10.35% over the last month, and its yearly performance shows a 68.16% increase. See more dynamics on GNOM price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 12.47% over the last month, showed a 23.28% increase in three-month performance and has increased by 77.82% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 12.47% over the last month, showed a 23.28% increase in three-month performance and has increased by 77.82% in a year.
GNOM trades at a premium (1.80%) meaning the ETF is trading at a higher price than the calculated NAV.